A Randomized, Double-Blind, Multicenter, Phase III Study to Compare Clinical Efficacy and Safety of HLX10 (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Injection) in Combination with Chemotherapy (Carboplatin-Etoposide) in Previously Untreated Patients with ES-SCLC
| Title | A Randomized, Double-Blind, Multicenter, Phase III Study to Compare Clinical Efficacy and Safety of HLX10 (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Injection) in Combination with Chemotherapy (Carboplatin-Etoposide) in Previously Untreated Patients with ES-SCLC |
|---|---|
| Description | At screening, blood samples and tumor tissue samples must be collected for biomarkers detecting |
| Organism | Homo sapiens |
| Data Type | Biomarker Data |
| Data Accessibility | Open-access |
| BioProject | PRJCA014383 |
| Release Date | 2023-01-13 |
| Submitter | nan zhao (1165095416@qq.com) |
| Organization | Jilin Cancer Hospital |
| Submission Date | 2023-01-12 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX002798-01 | MSITMB | 1 | Biomarker Data | 12.0 KB | zip | 0 |